These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31032344)

  • 21. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003-2014).
    Arana DM; Rubio M; Alós JI
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):293-298. PubMed ID: 27056582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
    Mumtaz K; Munir S; Muddassir M; Raza A; Waqas K; Shoaib Ahmed S; Malik A; Haider Naqvi SZ
    Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1111-1118. PubMed ID: 34602440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.
    Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE
    East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
    Duployez C; Loiez C; Cattoen C; Descamps D; Wallet F; Vachée A;
    Med Mal Infect; 2016 Dec; 46(8):436-441. PubMed ID: 27609597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.
    Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N
    J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
    Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is it possible to extrapolate the rates of resistance of Escherichia coli from asymptomatic bacteriuria in pregnant women to those of E. coli in uncomplicated community-acquired UTI?
    Asenjo A; Grados MC; Oteo-Iglesias J; Alós JI
    Rev Esp Quimioter; 2019 Aug; 32(4):375-378. PubMed ID: 31328907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P; Garzón D; Mattar S
    Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA; Kumar A
    Ann Saudi Med; 2005; 25(3):239-42. PubMed ID: 16119526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
    Popejoy MW; Paterson DL; Cloutier D; Huntington JA; Miller B; Bliss CA; Steenbergen JN; Hershberger E; Umeh O; Kaye KS
    J Antimicrob Chemother; 2017 Jan; 72(1):268-272. PubMed ID: 27707990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region].
    Marijan T; Plecko V; Vranes J; Dzepina AM; Bedenić B; Kalenić S
    Med Glas (Zenica); 2010 Feb; 7(1):46-53. PubMed ID: 20387724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility and emerging resistance determinants (blaCTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco.
    Bartoloni A; Sennati S; Di Maggio T; Mantella A; Riccobono E; Strohmeyer M; Revollo C; Villagran AL; Pallecchi L; Rossolini GM
    Int J Infect Dis; 2016 Feb; 43():1-6. PubMed ID: 26686940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.
    Rosello A; Hayward AC; Hopkins S; Horner C; Ironmonger D; Hawkey PM; Deeny SR
    J Antimicrob Chemother; 2017 Apr; 72(4):1184-1192. PubMed ID: 28077671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study.
    Matthews PC; Barrett LK; Warren S; Stoesser N; Snelling M; Scarborough M; Jones N
    BMC Infect Dis; 2016 Oct; 16(1):556. PubMed ID: 27729016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Seo YB; Lee J; Kim YK; Lee SS; Lee JA; Kim HY; Uh Y; Kim HS; Song W
    BMC Infect Dis; 2017 Jun; 17(1):404. PubMed ID: 28592240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.